Veterinary Medicines

Buserelin aniMedica 0,004 mg/ml solution for injection for cattle, horses, rabbits

Authorised
  • Buserelin acetate
Download as PDF

Product identification

Medicine name:
Buserelin aniMedica 0,004 mg/ml solution for injection for cattle, horses, rabbits
Buserelin aniMedica 0,004 mg/ml roztwór do wstrzykiwań dla bydła, koni i królików
Active substance:
  • Buserelin acetate
Target species:
  • Cattle
  • Horse
  • Rabbit
Route of administration:
  • Intramuscular use
  • Subcutaneous use
  • Intravenous use

Product details

Active substance and strength:
  • Buserelin acetate
    0.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Horse
      • Milk
        0
        day
      • Meat and offal
        0
        day
    • Rabbit
      • Meat and offal
        0
        day
  • Subcutaneous use
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Horse
      • Milk
        0
        day
      • Meat and offal
        0
        day
    • Rabbit
      • Meat and offal
        0
        day
  • Intravenous use
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Horse
      • Milk
        0
        day
      • Meat and offal
        0
        day
    • Rabbit
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QH01CA90
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Poland
Package description:
  • (ID14) 50 millilitre(s): unspecified outer container with 5 Vial (Glass) each with 10 millilitre(s)
  • (ID4) 5000 millilitre(s): unspecified outer container with 100 unspecified outer container each with 5 Vial (Glass) each with 10 millilitre(s)
  • (ID3) 2500 millilitre(s): unspecified outer container with 50 unspecified outer container each with 5 Vial (Glass) each with 10 millilitre(s)
  • (ID2) 1000 millilitre(s): unspecified outer container with 20 unspecified outer container each with 5 Vial (Glass) each with 10 millilitre(s)
  • (ID1) 500 millilitre(s): unspecified outer container with 10 unspecified outer container each with 5 Vial (Glass) each with 10 millilitre(s)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Well-established use application (Article 13a of Directive No 2001/82/EC)
Marketing authorisation holder:
  • aniMedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • aniMedica GmbH
Responsible authority:
  • Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
  • 1665
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0110/001
Concerned member states:
  • Austria
  • France
  • Poland
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 27/01/2025
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 27/01/2025
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 27/01/2025
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."